Pall ForteBio, a division of Pall Corp, supplier of instrumentation and analytics for accelerated drug discovery and development, has announced commercial availability of a new Dip and Read Anti-CHO (Chinese hamster ovary) Host Cell Protein (HCP) detection kit for quantitation of residual HCPs. Users will benefit from faster time to results, enhanced range of detection and better assay precision, all of which accelerate the drug development timeline while improving safety and efficacy. The kit can also be applied in production phases to confirm reduction or removal of HCP, increasing efficiency and speed of production.
“The commonly used ELISA HCP analytical method can require up to overnight analysis and must be monitored. Our new Dip and Read high-precision assay kit, in combination with the Octet HTX system, is hands-free, and only takes around an hour to analyse 96 samples with detection sensitivity as low as 0.5 ng/mL,” said Yves Baratelli, President, Pall Life Sciences.
EP News Bureau – Mumbai
